Immediate Impact

2 by Nobel laureates 1 from Science/Nature 65 hit
Sub-graph 1 of 23

Citing Papers

Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Hit
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
2023 Hit
2 intermediate papers

Works of Mark Lowrey being referenced

Effectiveness of Florbetapir PET Imaging in Changing Patient Management
2017
Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
2012

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Lowrey 251 223 116 92 35 5 339
Jason Burns 220 0.9× 194 0.9× 152 1.3× 101 1.1× 29 0.8× 4 376
Allison Fero 211 0.8× 202 0.9× 103 0.9× 111 1.2× 22 0.6× 4 309
Michelle Zanette 229 0.9× 223 1.0× 82 0.7× 86 0.9× 34 1.0× 9 313
Krishnendu Saha 223 0.9× 198 0.9× 114 1.0× 93 1.0× 28 0.8× 9 318
Cynthia Olson 262 1.0× 193 0.9× 55 0.5× 61 0.7× 37 1.1× 8 385
Chiara Corbetta‐Rastelli 175 0.7× 193 0.9× 121 1.0× 56 0.6× 31 0.9× 9 389
Georgina Vinyes‐Junque 224 0.9× 99 0.4× 118 1.0× 33 0.4× 15 0.4× 8 328
S.N.M. Schoonenboom 250 1.0× 263 1.2× 76 0.7× 26 0.3× 67 1.9× 7 383
Jarith L. Ebenau 229 0.9× 195 0.9× 56 0.5× 33 0.4× 44 1.3× 14 359
Bharath Rathakrishnan 144 0.6× 117 0.5× 63 0.5× 22 0.2× 31 0.9× 6 340

All Works

Loading papers...

Rankless by CCL
2026